Christoph Buchta, Wim Coucke, Wolfgang Huf, Andrea Griesmacher, Mathias M Müller, Wolfgang R Mayr, Øystein Flesland, Constantina Politis, Johanna Wiersum-Osselton, Andrés Aburto, Tony Badrick, Lobna Bouacida, Marek Budina, Joseph A Duenas, Wolf-Jochen Geilenkeuser, André V P Guimarães, Ana Hecimovic, Markus Jutzi, Chang-Keun Lee, Young Ae Lim, Joy Mammen, Petra Magdolna Molnár, Azita Mokhtari, Giuseppa Morabito, Eduardo Muñiz-Diaz, Truscha Niekerk, Anja Pakkanen, Paola Pezzati, Razvan Popa, Erika Sárkány, Jean-Pascal Siest, Dhitiwass Suvagandha, Marc Thelen, Jenny Ullhagen, Dalius Vitkus, Günther F Körmöczi
OBJECTIVES: Medical laboratories may, at their own discretion, exceed but not undercut regulatory quality requirements. Available economic resources, however, may drive or hinder eagerness to exceed minimum requirements. Depending on the respective scopes of regulatory and economic framework conditions, differing levels of quality efforts to safeguard laboratory performance can be anticipated. However, this has not yet been investigated. METHODS: Immunohaematology external quality assessment (EQA) results collected by 26 EQA providers from their participant laboratories in 73 countries from 2004 to 2019 were evaluated...
February 23, 2022: Clinical Chemistry and Laboratory Medicine: CCLM